Camden National Corporation (NASDAQ:CAC) Files An 8-K Regulation FD Disclosure
Item 7.01
|
Regulation FD Disclosure.
|
presentation with information about the Company for an investor
conference to be held on March 8, 2017. The investor presentation
is attached as Exhibit 99.1. The investor presentation is being
furnished to Item 7.01, and the information contained therein
shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, or otherwise subject to the
liabilities under that Section. Furthermore, the information
contained in Exhibit 99.1 shall not be deemed to be incorporated
by reference into the filings of the Company under the Securities
Act of 1933.
|
Item 9.01
|
Financial Statements and Exhibits.
|
|
Exhibit No.
|
Description
|
|
99.1
|
Electronic investor presentation slides.
|
About Camden National Corporation (NASDAQ:CAC)
Camden National Corporation is a bank holding company. The Company is a diversified financial services provider. The primary business of the Company and its subsidiaries is to attract deposits from, and to extend loans to, consumer, institutional, municipal, non-profit and commercial customers. The Company offers commercial and consumer banking products and services through its subsidiary, Camden National Bank (the Bank), and brokerage and insurance services through Camden Financial Consultants (Camden Financial), a division of the Bank. The Company also offers investment management and fiduciary services through its subsidiary, Acadia Trust, N.A. (Acadia Trust), a federally-regulated, non-depository trust company headquartered in Portland, Maine. The Bank’s subsidiary, Healthcare Professional Funding Corporation (HPFC), provides specialized lending to dentists, optometrists and veterinarians across the United States. Camden National Corporation (NASDAQ:CAC) Recent Trading Information
Camden National Corporation (NASDAQ:CAC) closed its last trading session 00.00 at 42.15 with 25,727 shares trading hands.
